Hindusthan Chemists & Druggists Co Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.13 M
- Company Age 86 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 90.63%
- Profit Growth 14.35%
- Ebitda 6.28%
- Net Worth 18.23%
- Total Assets -29.05%
About Hindusthan Chemists & Druggists Co
Hindusthan Chemists & Druggists Co Pvt Ltd (HCDCPL) was founded in India on 21 February 1939 and has a glorious history of 86 years .Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Avijit Paul, Amit Paul, Avideep Paul, and One other member serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397WB1939PTC009604
- Company No.
009604
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 1939
- Date of AGM
14 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Hindusthan Chemists & Druggists Co?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avijit Paul  | Director | 03-Apr-2006 | Current |
| Amit Paul | Director | 03-Apr-2006 | Current |
| Avideep Paul | Director | 01-Jul-2022 | Current |
| Avirup Paul | Director | 01-Jul-2022 | Current |
Financial Performance of Hindusthan Chemists & Druggists Co.
Hindusthan Chemists & Druggists Co Pvt Ltd, for the financial year ended 2017, experienced significant growth in revenue, with a 90.63% increase. The company also saw a substantial improvement in profitability, with a 14.35% increase in profit. The company's net worth Soared by an impressive increase of 18.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hindusthan Chemists & Druggists Co?
In 2017, Hindusthan Chemists & Druggists Co had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hindusthan Chemists & Druggists Co?
Unlock and access historical data on people associated with Hindusthan Chemists & Druggists Co, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindusthan Chemists & Druggists Co, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindusthan Chemists & Druggists Co's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.